NCT03696381

Brief Summary

The main objective of this study is to evaluate the effects of tRNS while undergoing computerized cognitive rehabilitation therapy to conclude if this combination of therapies would be effective for the cognitive rehabilitation of patients with acquired brain damage, such as traumatic brain injury. We want to study the therapeutic potential of tRNS to enhance the therapeutic outcome of cognitive training, studying its global effect over the rehabilitation of attention, memory and executive functions, compared to sham tRNS.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 3, 2018

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 4, 2018

Completed
5 months until next milestone

Study Start

First participant enrolled

February 25, 2019

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2019

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2020

Completed
Last Updated

February 26, 2019

Status Verified

February 1, 2019

Enrollment Period

6 months

First QC Date

October 3, 2018

Last Update Submit

February 25, 2019

Conditions

Keywords

computerized cognitive rehabilitationtrnstraumatic brain injurytbicognitive impairment

Outcome Measures

Primary Outcomes (6)

  • Conners Continuous Performance Test (CPT-II)

    To improve performance in sustained attention after receiving experimental intervention.

    1 day

  • Digit Span Forward from the Wechsler Adult Intelligence Scale

    To improve performance in span of immediate verbal recall after receiving experimental intervention.

    1 day

  • Digit Span Backward from the Wechsler Adult Intelligence Scale

    To improve performance in working memory after receiving experimental intervention.

    1 day

  • Rey Auditory Verbal Learning Test

    To improve performance in short-term, long-term and recognition.

    1 day

  • Letters and Numbers from the Wechsler Adult Intelligence Scale

    To improve performance in working memory after receiving experimental intervention.

    1 day

  • Spanish phonemic fluency test (PMR)

    To improve performance in phonemic fluency after receiving experimental intervention.

    1 day

Secondary Outcomes (4)

  • Trail Making Test A (TMT-A)

    1 day

  • Trail Making Test B (TMT-B)

    1 day

  • Wisconsin Card Sorting Test (WCST)

    1 day

  • Stroop Color and Word test (Stroop Test)

    1 day

Study Arms (2)

Real tRNS

EXPERIMENTAL

Real tRNS + Guttmann NeuroPersonalTrainer (GNPT) 3 days per week over 8 weeks.

Other: Real tRNS

Sham tRNS

SHAM COMPARATOR

Sham tRNS + Guttmann NeuroPersonalTrainer (GNPT) 3 days per week over 8 weeks.

Other: Sham tRNS

Interventions

The treatment consists of a set of 1-h sessions, three sessions per week for 8 weeks. A series of cognitive exercises of attention, memory, and executive functions will be conducted in each session. During the first 20 minutes of each cognitive training session, patients will receive bi-frontal and bi-parietal tRNS. It has a start and end ramp of two seconds in each case to avoid the slight unpleasant sensation that occurs in the first moments of the introduction of direct current DC.

Also known as: Guttmann, NeuroPersonalTrainer (GNPT)
Real tRNS

The treatment consists of a set of 1-h sessions, three sessions per week for 8 weeks. A series of cognitive exercises of attention, memory, and executive functions will be conducted in each session. We will apply a sham tRNS for the first 20 minutes of each cognitive training session. The subjects will receive sham tRNS and will perform the same type of cognitive training as the rest of patients and will receive the same type of adverse reaction questionnaire. Subjects receiving simulated stimulation will receive the same type of ramps at the beginning and end of the session to ensure triple-blind maintenance .

Also known as: Guttmann, NeuroPersonalTrainer (GNPT)
Sham tRNS

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age over 18 years old
  • documented history of severe or moderate TBI (severe TBI: Glasgow Coma Scale 3-8; moderate TBI: Glasgow Coma Scale 9-13)
  • out of post-traumatic amnesia
  • less than 6 months after TBI
  • cognitive impairment objectified by neuropsychological exploration.

You may not qualify if:

  • impairment of language, affecting the production and/or comprehension of speech and the ability to read and/or write
  • severe alteration of the visual field or visual perception problems that limits the use of technological devices
  • sever motor impairment of both upper extremities that prevent the use of technological devices
  • previous or current history of psychiatric, neurological or systemic alterations that affect the central nervous system
  • history of substance abuse
  • dermatological diseases in the skull
  • presence of metal implants or holes in the skull
  • epilepsy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institut Guttmann

Badalona, Barcelona, 08916, Spain

RECRUITING

MeSH Terms

Conditions

Brain Injuries, TraumaticCognitive Dysfunction

Condition Hierarchy (Ancestors)

Brain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesCognition DisordersNeurocognitive DisordersMental Disorders

Central Study Contacts

Adria Garcia Rosas

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD Student

Study Record Dates

First Submitted

October 3, 2018

First Posted

October 4, 2018

Study Start

February 25, 2019

Primary Completion

September 1, 2019

Study Completion

December 1, 2020

Last Updated

February 26, 2019

Record last verified: 2019-02

Locations